These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33854297)

  • 21. Bilateral 0.19 mg Fluocinolone Acetonide Intravitreal Implant in the Successful Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis and Secondary Macular Oedema: A Case Report and Review of Intravitreal Therapies.
    Ansari AS; Amir Z; Williams GS
    Ophthalmol Ther; 2021 Mar; 10(1):193-200. PubMed ID: 33464558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fluocinolone acetonide (ILUVIEN®) micro-implant for chronic diabetic macular edema].
    Soubrane G; Behar-Cohen F
    J Fr Ophtalmol; 2015 Feb; 38(2):159-67. PubMed ID: 25601517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re: Jaffe et al.: Injectable fluocinolone acetonide long-acting implant for noninfectious intermediate uveitis, posterior uveitis, and panuveitis: 2-year results (Ophthalmology. 2016;123:1940-1948).
    Shrivastav A; Mayor R; Agarwal M; Venkatesh R; Singh S
    Ophthalmology; 2017 Aug; 124(8):e62. PubMed ID: 28734339
    [No Abstract]   [Full Text] [Related]  

  • 24. Re: Jaffe et al.: Injectable fluocinolone acetonide long-acting implant for noninfectious intermediate uveitis, posterior uveitis, and panuveitis: two-year results (Ophthalmology. 2016;123:1940-1948).
    Agrawal R
    Ophthalmology; 2017 Apr; 124(4):e45. PubMed ID: 28335961
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence and management of elevated intraocular pressure after placement of an intravitreal sustained-release steroid implant.
    Bollinger KE; Smith SD
    Curr Opin Ophthalmol; 2009 Mar; 20(2):99-103. PubMed ID: 19248312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and Safety of Corticosteroid Implants in Non-infectious Uveitis: A Systematic Review with Network Meta-analysis.
    Vieira R; Sousa-Pinto B; Figueira L
    Ocul Immunol Inflamm; 2022 Jan; 30(1):215-222. PubMed ID: 32809890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aqueous levels of fluocinolone acetonide after administration of fluocinolone acetonide inserts or fluocinolone acetonide implants.
    Campochiaro PA; Nguyen QD; Hafiz G; Bloom S; Brown DM; Busquets M; Ciulla T; Feiner L; Sabates N; Billman K; Kapik B; Green K; Kane FE;
    Ophthalmology; 2013 Mar; 120(3):583-587. PubMed ID: 23218184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined Ahmed Glaucoma Valve Placement, Intravitreal Fluocinolone Acetonide Implantation and Cataract Extraction for Chronic Uveitis.
    Chang IT; Gupta D; Slabaugh MA; Vemulakonda GA; Chen PP
    J Glaucoma; 2016 Oct; 25(10):842-846. PubMed ID: 27300641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of fluocinolone acetonide sustained release implant (Retisert) dissociation during implant removal and exchange surgery.
    Nicholson BP; Singh RP; Sears JE; Lowder CY; Kaiser PK
    Am J Ophthalmol; 2012 Dec; 154(6):969-973.e1. PubMed ID: 22981365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to Comment on "Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-Infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal".
    Pouwels XGLV; Petersohn S; Carrera VH; Denniston AK; Chalker A; Raatz H; Armstrong N; Witlox W; Worthy G; Noake C; Riemsma R; Kleijnen J; Joore MA
    Pharmacoeconomics; 2020 Jun; 38(6):649-651. PubMed ID: 32249398
    [No Abstract]   [Full Text] [Related]  

  • 31. Comment on 'Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal'.
    Jacob I; Butler K; Badora K; Gross V; Beiderbeck A; Morris S; McEwan P
    Pharmacoeconomics; 2020 Jun; 38(6):645-648. PubMed ID: 32249397
    [No Abstract]   [Full Text] [Related]  

  • 32. Fluocinolone acetonide intravitreal implant as a therapeutic option for severe Sjögren's syndrome-related keratopathy: a case report.
    Wasielica-Poslednik J; Pfeiffer N; Gericke A
    J Med Case Rep; 2019 Jan; 13(1):21. PubMed ID: 30674351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.
    Jaffe GJ; Martin D; Callanan D; Pearson PA; Levy B; Comstock T;
    Ophthalmology; 2006 Jun; 113(6):1020-7. PubMed ID: 16690128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic macular edema outcomes in eyes treated with fluocinolone acetonide 0.2 µg/d intravitreal implant: real-world UK experience.
    El-Ghrably I; Steel DHW; Habib M; Vaideanu-Collins D; Manvikar S; Hillier RJ
    Eur J Ophthalmol; 2017 May; 27(3):357-362. PubMed ID: 28165610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time to disease recurrence in noninfectious uveitis following long-acting injectable fluocinolone acetonide implant.
    Cai CX; Skalak C; Keenan RT; Grewal DS; Jaffe GJ
    Graefes Arch Clin Exp Ophthalmol; 2020 May; 258(5):1023-1030. PubMed ID: 32114654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FLUOCINOLONE ACETONIDE IMPLANT FOR VOGT-KOYANAGI-HARADA DISEASE: Three-Year Outcomes of Efficacy and Safety.
    Heo JW; Cho BJ; Goldstein DA; Sepah YJ; Do DV; Nguyen QD
    Retina; 2016 Nov; 36(11):2124-2131. PubMed ID: 27333235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reimplantation of a fluocinolone acetonide sustained drug delivery implant for chronic uveitis.
    Jaffe GJ
    Am J Ophthalmol; 2008 Apr; 145(4):667-675. PubMed ID: 18226800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluocinolone acetonide intravitreal sustained release device--a new addition to the armamentarium of uveitic management.
    Brumm MV; Nguyen QD
    Int J Nanomedicine; 2007; 2(1):55-64. PubMed ID: 17722513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of fluocinolone acetonide intravitreal implant (0.59 mg) in birdshot retinochoroidopathy.
    Bajwa A; Aziz K; Foster CS
    Retina; 2014 Nov; 34(11):2259-68. PubMed ID: 24999722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment Trial and Follow-up Study.
    Multicenter Uveitis Steroid Treatment (MUST) Trial Follow-up Study Research Group
    Ophthalmology; 2015 Oct; 122(10):1976-86. PubMed ID: 26298718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.